|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 9/01/20 Chemed Corp. 8-K:5 8/31/20 10:174K |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 27K 6: R1 Document And Entity Information HTML 45K 8: XML IDEA XML File -- Filing Summary XML 11K 5: XML XBRL Instance -- che-20200831x8k_htm XML 15K 7: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.LAB XBRL Labels -- che-20200831_lab XML 56K 4: EX-101.PRE XBRL Presentations -- che-20200831_pre XML 32K 2: EX-101.SCH XBRL Schema -- che-20200831 XSD 11K 9: JSON XBRL Instance as JSON Data -- MetaLinks 11± 17K 10: ZIP XBRL Zipped Folder -- 0000019584-20-000036-xbrl Zip 9K
| che-20200831x8k |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):
i CHEMED CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
i Delaware | i 1-8351 | i 31-0791746 |
(State
or other | (Commission File Number) | (I.R.S. Employer |
i 2600 First Financial Center, 255 East 5th Street, i Cincinnati, i OH i 45202
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
( i 513) i 762-6690
|
|
|
Title of each class |
Trading symbol | Name of each exchange on which registered |
i Capital stock $1 par value | i CHE | i NYSE |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
i [_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i [_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
i [_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))
i [_] Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))
Securities registered pursuant to 12(b) of the Act:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company i [_]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]
Item 5.02 Departure of Directors or Certain Officers; Election of Directors: Appointment of Certain Officers, Compensatory Arrangements of Certain Officers.
Retirement of Naomi C. Dallob
Effective August 31, 2020, Naomi C. Dallob, Vice President, Chief Legal Officer and Secretary of Chemed Corporation, retired after 36 years of service.
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
| CHEMED CORPORATION | |
|
|
|
Dated: September 1, 2020 | By: | |
|
| |
|
| Vice President and Controller |
|
|
|
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 9/1/20 | None on these Dates | ||
| For Period end: | 8/31/20 | |||
| List all Filings | ||||